老年慢性肺心病并发Ⅱ型呼衰患者应用BiPAP治疗的疗效及可行性研究

Efficacy and Feasibility Study of BiPAP in the Treatment of Elderly Patients with Chronic Pulmonary Heart Disease with Type Ⅱ Respiratory Failure

目的:研究老年慢性肺心病并发Ⅱ型呼衰患者应用BiPAP治疗的疗效及可行性。方法:随机选取2013年2月-2015年12月本院收治的老年慢性肺心病并发Ⅱ型呼衰患者142例,依据辅助通气方法将其分为两组,即BiPAP治疗组和常规治疗组,每组71例。对两组RR、HR、血气分析检测指标及CRP水平、临床疗效进行统计分析。结果:BiPAP治疗组RR、HR均低于常规治疗组,SaO_2、PaO_2水平均高于常规治疗组,PaCO_2、CRP水平均低于常规治疗组(P<0.05),总有效率85.9%(61/71)高于常规治疗组的54.9%(39/71),差异均有统计学意义(P<0.05)。结论:老年慢性肺心病并发Ⅱ型呼衰患者应用BiPAP治疗的疗效显著,具有较高的可行性。

Objective： To study the efficacy and feasibility of BiPAP in the treatment of elderly patients with chronic pulmonary heart disease with type Ⅱ respiratory failure.Method ： 142 cases of elderly patients with chronic pulmonary heart disease with type II respiratory failure in our hospital from February 2013 to December 2015 were randomly selected, these patients were divided into BiPAP treatment group and conventional therapy group according to the method of assisted ventilation, 71 cases in each group.RR, HR, blood gas analysis and detection indicators, CRP levels and clinical effects of two groups were analyzed.Result： RR, HR of BiPAP treatment group were significantly lower than those of conventional therapy group, SaO2, PaO2 were significantly higher than those of conventional therapy group, PaCO2, CRP levels were significantly lower than those of conventional therapy group, the total treatment effective rate was 85.9% （61/71）, which was higher than that of the conventional treatment group＇s 54.9% （ 39/71 ）, the differences were statistic significant （ P〈0.05 ） . Conclusion： The efficacy of BiPAP in the treatment of elderly patients with chronic pulmonary heart disease with type Ⅱ respiratory failure is significant, it has high feasibility.